Core Laboratories Inc. (CLB)
NYSE: CLB · Real-Time Price · USD
9.11
+0.10 (1.11%)
Nov 13, 2026, 4:00 PM EST - Market closed

Core Laboratories Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
516.74526.52523.85509.79489.74470.25
Revenue Growth
-0.15%0.51%2.76%4.09%4.14%-3.49%
Cost of Revenue
418.05417.59420.52399.96393.66367.9
Gross Profit
98.69108.93103.33109.8396.08102.36
Selling, General & Admin
46.2244.2338.5938.8937.5743.87
Amortization of Goodwill & Intangibles
0.520.360.50.490.690.76
Other Operating Expenses
-1.28-1.66-2.32-1.81-1.71-1.32
Operating Expenses
59.9357.2151.2352.8753.0361.06
Operating Income
38.7651.7252.156.9743.0541.3
Interest Expense
-11.13-10.57-12.37-13.43-11.57-9.15
Earnings From Equity Investments
-0.65-0.650.240.390.290.06
Currency Exchange Gain (Loss)
-1.05-0.75-1.2-0.18-0.230.23
EBT Excluding Unusual Items
25.9339.7538.7743.7531.5532.44
Merger & Restructuring Charges
-0.64-2.96-2.79-2.29-3.33-
Gain (Loss) on Sale of Assets
1.720.811.780.21.071.44
Other Unusual Items
----0.46--
Pretax Income
27.845.946.1941.2129.9536.11
Income Tax Expense
12.1715.5114.034.1810.315.89
Earnings From Continuing Operations
15.6430.3932.1537.0319.6620.22
Net Income to Company
15.6430.3932.1537.0319.6620.22
Minority Interest in Earnings
-0.08-0.72-0.75-0.35-0.21-0.49
Net Income
15.5629.6731.436.6819.4519.73
Net Income to Common
15.5629.6731.436.6819.4519.73
Net Income Growth
-51.57%-5.51%-14.38%88.53%-1.39%-
Shares Outstanding (Basic)
464647474646
Shares Outstanding (Diluted)
474748484747
Shares Change
-1.68%-1.38%0.34%1.52%0.26%4.98%
EPS (Basic)
0.340.640.670.790.420.43
EPS (Diluted)
0.340.630.660.770.420.42
EPS Growth
-50.28%-4.54%-14.29%83.40%-0.04%-

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
6.6722.4443.3614.2114.7423.04
Free Cash Flow Per Share
0.140.480.910.300.320.49
Dividend Per Share
0.0400.0400.0400.0400.0400.040
Dividend Growth
0%0%0%0%0%-85.71%
Gross Margin
19.10%20.69%19.72%21.55%19.62%21.77%
Operating Margin
7.50%9.82%9.95%11.17%8.79%8.78%
Profit Margin
3.01%5.63%5.99%7.19%3.97%4.20%
Free Cash Flow Margin
1.29%4.26%8.28%2.79%3.01%4.90%
EBITDA
53.7466.3767.0572.7560.2259.81
EBITDA Margin
10.40%12.61%12.80%14.27%12.29%12.72%
D&A For EBITDA
14.9814.6514.9515.7817.1618.52
EBIT
38.7651.7252.156.9743.0541.3
EBIT Margin
7.50%9.82%9.95%11.17%8.79%8.78%
Effective Tax Rate
43.76%33.78%30.39%10.15%34.37%44.01%
Revenue as Reported
516.74526.52523.85509.79489.74470.25
SEC Filings: 10-K · 10-Q